RAC 1.27% $1.55 race oncology ltd

The RAC 3-Pillar Trifecta, page-219

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    Arcus Biosciences will be interesting to watch.



    Partnership with Gilead signed in May 2020 - height of Pandemic:
    • USD $175m upfront
    • USD $200m equity investment
    • USD $1.6B in milestones
    https://www.gilead.com/news-and-pre...ialize-next-generation-cancer-immunotherapies

    Current Market cap USD $2.4B.

    Here's their pipeline:
    • Lung Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Pancreatic Cancer
    • Triple-negative Breast Cancer

    Screen Shot 2021-01-16 at 11.10.21 am.png
    Some parallel's to RACE's strategy for FTO
    (RACE looking at making the PD-1 inhibitors work better for melanoma).

    Screen Shot 2021-01-16 at 11.23.34 am.png

    Have added the partnership to my database.

    Average total partnership value for this group is currently USD $1.5B.

    Screen Shot 2021-01-16 at 11.32.09 am.png
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.